Marc-André Weber1, Andrea Baur-Melnyk2. 1. Institut für Diagnostische und Interventionelle Radiologie, Kinder- und Neuroradiologie, Universitätsmedizin Rostock, Ernst-Heydemann-Str. 6, 18057, Rostock, Deutschland. marc-andre.weber@med.uni-rostock.de. 2. Klinik und Poliklinik für Radiologie, Klinikum der LMU-Großhadern, München, Deutschland.
Abstract
CLINICAL ISSUE: Multiple myeloma is a clonal B‑lymphocyte neoplasm of terminally differentiated plasma cells and accounts for approximately 10% of all hematologic malignancies. Reduction of bone mass, seen on computed tomography (CT) as focal osteolysis, or general osteopenia is mainly caused by tumor-induced resorption of bone. STANDARD RADIOLOGICAL METHODS: Imaging methods are used in multiple myeloma to record the extent of various dimensions of the disease manifestations (damage to bone substance, bone marrow infiltration, extramedullary involvement) and the disease course. The aim of this review article is to summarize and outline the recommendations of the S3 guideline "Diagnostics, therapy and follow-up care for patients with monoclonal gammopathy of unclear significance (MGUS) or multiple myeloma" in terms of radiographic imaging. APPRAISAL AND PRACTICAL RECOMMENDATIONS: The use of the conventional X‑ray skeletal status (Paris scheme) is obsolete. When a patient with symptomatic multiple myeloma is initially diagnosed, a whole-body CT should be performed to determine the extent of skeletal damage. The S3 guideline also regards CT as the first imaging modality in relapse and progression.
CLINICAL ISSUE: Multiple myeloma is a clonal B‑lymphocyte neoplasm of terminally differentiated plasma cells and accounts for approximately 10% of all hematologic malignancies. Reduction of bone mass, seen on computed tomography (CT) as focal osteolysis, or general osteopenia is mainly caused by tumor-induced resorption of bone. STANDARD RADIOLOGICAL METHODS: Imaging methods are used in multiple myeloma to record the extent of various dimensions of the disease manifestations (damage to bone substance, bone marrow infiltration, extramedullary involvement) and the disease course. The aim of this review article is to summarize and outline the recommendations of the S3 guideline "Diagnostics, therapy and follow-up care for patients with monoclonal gammopathy of unclear significance (MGUS) or multiple myeloma" in terms of radiographic imaging. APPRAISAL AND PRACTICAL RECOMMENDATIONS: The use of the conventional X‑ray skeletal status (Paris scheme) is obsolete. When a patient with symptomatic multiple myeloma is initially diagnosed, a whole-body CT should be performed to determine the extent of skeletal damage. The S3 guideline also regards CT as the first imaging modality in relapse and progression.
Authors: J Hillengass; L A Moulopoulos; S Delorme; V Koutoulidis; J Mosebach; T Hielscher; M Drake; S V Rajkumar; B Oestergaard; N Abildgaard; M Hinge; T Plesner; Y Suehara; K Matsue; N Withofs; J Caers; A Waage; H Goldschmidt; M A Dimopoulos; S Lentzsch; B Durie; E Terpos Journal: Blood Cancer J Date: 2017-08-25 Impact factor: 11.037
Authors: Lia A Moulopoulos; Vassilis Koutoulidis; Jens Hillengass; Elena Zamagni; Jesus D Aquerreta; Charles L Roche; Suzanne Lentzsch; Philippe Moreau; Michele Cavo; Jesus San Miguel; Meletios A Dimopoulos; S Vincent Rajkumar; Brian G M Durie; Evangelos Terpos; Stefan Delorme Journal: Blood Cancer J Date: 2018-10-04 Impact factor: 11.037